For decades, men on TRT had a limited menu of delivery methods: injections, topical gels, patches, or implanted pellets. Each has trade-offs — needles, skin transfer risk, application hassle, or surgical insertion. The idea of simply swallowing a pill has been a long-standing wish.
Kyzatrex makes that possible. Approved by the FDA in August 2022, Kyzatrex (testosterone undecanoate) is the first oral testosterone replacement therapy that avoids the liver toxicity problems that plagued earlier oral formulations. In 2026, it's gaining significant traction — particularly through Hims' exclusive partnership with manufacturer Marius Pharmaceuticals.
What Is Kyzatrex?
Kyzatrex is a soft gel capsule containing testosterone undecanoate dissolved in a lipid-based carrier. It's taken twice daily with food — once in the morning, once in the evening. Available in three dosage strengths: 100mg, 150mg, and 200mg.
It's currently indicated for adult men with hypogonadism caused by specific medical conditions. Like all testosterone products, it's classified as a Schedule III controlled substance and requires a prescription.
How It Works (Lymphatic Absorption)
Earlier attempts at oral testosterone failed because the medication was absorbed through the portal vein and processed by the liver first (first-pass metabolism). This caused liver stress and, in some formulations, serious hepatotoxicity.
Kyzatrex solves this by using a lipid-based formulation that's absorbed through the lymphatic system instead. When you take it with food (specifically, dietary fat), the testosterone undecanoate dissolves into the intestinal lymph and enters the bloodstream via the thoracic duct — completely bypassing the liver.
Once in circulation, the undecanoate ester is cleaved off by natural enzymes, releasing free testosterone. The undecanoic acid (a C-11 fatty acid) is then metabolized harmlessly through beta-oxidation.
Why This Matters
Kyzatrex's lymphatic absorption pathway means it avoids the liver toxicity that killed earlier oral testosterone products. It's not a "methylated" steroid like the old oral formulations — it's a fundamentally different delivery mechanism.
Efficacy: What the Clinical Data Shows
The FDA approval was based on a Phase III trial of 139 hypogonadal men:
- 88% of patients achieved normal testosterone levels (222-800 ng/dL) by day 90
- The medication approximately doubles free testosterone on average
- Median patient age was 50 years (range 22-66)
- Dosing was adjustable between 100mg once daily and 400mg twice daily based on individual response
A separate retrospective chart review presented at the 2024 Sexual Medicine Society meeting found that starting at a higher dose (400mg twice daily) was safe, effective, and associated with high patient satisfaction, with nearly all patients (26 of 27) reporting symptom improvement and continuing treatment.
Side Effects and Monitoring
Kyzatrex carries a boxed warning about blood pressure increases — this is the most notable safety signal. Key side effects from clinical data include:
- Increased blood pressure: The most clinically significant concern. Blood pressure monitoring before and during treatment is required
- Elevated hematocrit: As with all forms of TRT, red blood cell production increases. Regular blood work is essential
- Headache, back pain, joint pain: Commonly reported but generally mild
- GI effects: Some patients report nausea, diarrhea, or constipation — expected with an oral medication
- Transient gastrointestinal upset: In the higher-dose study, 7.4% of patients experienced GI upset, though it resolved on its own
Like all exogenous testosterone, Kyzatrex suppresses natural testosterone production and spermatogenesis. Men who want to preserve fertility should discuss alternatives (like enclomiphene) or adjunctive therapies (like HCG) with their provider.
Kyzatrex vs Injectable TRT
| Factor | Kyzatrex (Oral) | Injectable Testosterone Cypionate |
|---|---|---|
| Delivery | Twice-daily capsule with food | 1-2 injections per week |
| Needles | None | Required |
| Efficacy | 88-96% achieve normal T levels | ~90%+ achieve normal T levels |
| Level Stability | Moderate (twice-daily dosing creates some fluctuation) | Good with 2x/week dosing |
| Cost | Higher (brand-name, cash-pay) | Lower (generic available) |
| Liver Safety | Bypasses liver (lymphatic) | Bypasses liver (injected) |
| Convenience | Very convenient — just take with meals | Requires injection supplies and technique |
| Travel | Easy — just pack capsules | Requires carrying needles/vials |
| Insurance | Typically cash-pay only | Sometimes covered by insurance |
Who Is Kyzatrex Best For?
Great fit:
- Men who are needle-averse and won't consider injections
- Frequent travelers who want hassle-free TRT on the go
- Men who prefer the discretion and simplicity of a daily pill
- Patients who've had skin reactions to topical gels or patches
Not ideal for:
- Budget-conscious patients — injectable generic testosterone cypionate is significantly cheaper
- Men who want the most stable serum levels — twice-daily dosing creates more fluctuation than optimized injection protocols
- Men who are already comfortable with injections and have a well-dialed protocol
Our Verdict
Kyzatrex is a meaningful innovation in testosterone delivery. It's not going to replace injections for most men — injectables remain more cost-effective and offer superior level stability — but it fills a real gap for men who won't or can't use needles.
The clinical data is solid: 88-96% efficacy in normalizing testosterone, manageable side effects, and high patient satisfaction. The blood pressure concern requires monitoring but is consistent with what we see across all forms of TRT.
If you've been putting off TRT because you don't want injections, Kyzatrex removes that barrier. And with Hims making it available through their telehealth platform in 2026, access just got significantly easier.
Explore Your TRT Options
Whether oral, injectable, or topical — our clinic comparison helps you find the right treatment and provider.
Compare TRT Clinics →